MALARIA VIVAX
Clinical trials for MALARIA VIVAX explained in plain language.
Never miss a new study
Get alerted when new MALARIA VIVAX trials appear
Sign up with your email to follow new studies for MALARIA VIVAX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New malaria combo aims to stop relapses for good
⭐️ CURE ⭐️ Not yet recruitingThis Phase 2b trial tests whether a new drug, SJ733, combined with tafenoquine can cure P. vivax malaria and prevent it from returning. About 104 adults with uncomplicated malaria will receive different schedules of SJ733 plus tafenoquine, or standard chloroquine plus tafenoquine…
Matched conditions: MALARIA VIVAX
Phase: PHASE2 • Sponsor: R. Kiplin Guy • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 12:38 UTC
-
New malaria vaccine vivaxin enters first human tests
⭐️ VACCINE ⭐️ Not yet recruitingThis early-stage trial is testing a new vaccine called Vivaxin, designed to protect against malaria caused by the Plasmodium vivax parasite. Researchers will give the vaccine to 48 healthy adults who have never had malaria, to check if it is safe and whether it triggers an immune…
Matched conditions: MALARIA VIVAX
Phase: PHASE1 • Sponsor: Federal University of Minas Gerais • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 17:21 UTC